homologous recombination deficiency

2:26
Trial design of ENGOT-OV16/NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer
Mansoor Mirza
3:10
Overview of ENGOT-OV16/NOVA of niraparib in ovarian cancer and why the results were not surprising
Ursula Matulonis
The content of VJOncology is intended for healthcare professionals